Position
First Command Advisory Services, Inc. in Alnylam Pharmaceuticals, Inc.
Back to the book · All holders of ALNY
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$200$397.67 → $330.92
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3 | $1.19K | — | — | — | 0.0% |
| Q1 2026 | 12 | $3.97K | $330.92 | −$200 | $2.98K | 0.0% |